Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2023 Mar 2;13:3571. doi: 10.1038/s41598-023-30736-3

Retraction Note: MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia

Zhu Xishan 1, Lin Ziying 1, Du Jing 2, Liu Gang 1,
PMCID: PMC9981588  PMID: 36864099

Retraction of: Scientific Reports 10.1038/srep12460, published online 31 July 2015

The Editors have retracted this article.

After publication the following concerns were raised:

  • Figure 6B (panel Fibronectin) appears to overlap with Figure 3B (panel PPM1D vs COLO-320 cells) of1.

  • Figure 6B (panel Actin) appears to overlap with Figure 3B (panel β-actin vs COLO-320 cells) of1.

  • Significant portions of text in this article overlap with text in2

The Editors therefore no longer have confidence in the results and conclusions presented.

The Editors were not able to obtain current email addresses for Zhu Xishan, Lin Ziying, Du Jing and Liu Gang.

References

  • 1.Peng TS, He YH, Nie T, Hu XD, Lu HY, Yi J, Shuai YF, Luo M. PPM1D is a prognostic marker and therapeutic target in colorectal cancer. Exp. Therap. Med. 2014;8(2):430–434. doi: 10.3892/etm.2014.1762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Peng Y, Liu YM, Li LC, Wang LL, Wu XL. MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PLoS ONE. 2014;9(4):e94422. doi: 10.1371/journal.pone.0094422. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES